$3.95
0.020.51%
al cierre: Aug 20, 5:00 PM EST
$4.11
0.164.05%
After hour: Aug 19, 7:29 AM EST
Neuphoria Therapeutics (NEUP) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.56 | $-1.01 | $-2.52 |
| Actual | $-0.09 | $-0.77 | $-4.41 | $-3.98 |
| Surprise | +83.9% | -37.5% | -336.6% | -57.9% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $-13267 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.56 | $-0.42 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | May 15, 2026 | $-0.09 | $-0.56 | 83.9 % |
| Q2 | Feb 17, 2026 | $-0.77 | $-0.56 | -37.5 % |
| Q1 | Nov 14, 2025 | $-4.41 | $-1.01 | -336.6 % |
| Q4 | Sep 29, 2025 | $-3.98 | $-2.52 | -57.9 % |